- Correction
- Open access
- Published:
Correction: Iguratimod attenuated fbrosis in systemic sclerosis via targeting early growth response 1 expression
Arthritis Research & Therapy volume 26, Article number: 34 (2024)
Correction: Arthritis Res Ther 25, 151 (2023)
https://doi.org/10.1186/s13075-023-03135-2
Following publication of the original article [1], the authors reported an error found in the Funding section, the grant number for Shanghai Municipal Commission of Health and Family Planning is incorrect. This should be corrected from “20204Y0088” to “20204Y0090”.
The original article [1] has been updated.
Reference
Shen L, Yin H, Sun L, et al. Iguratimod attenuated fibrosis in systemic sclerosis via targeting early growth response 1 expression. Arthritis Res Ther. 2023;25:151. https://doi.org/10.1186/s13075-023-03135-2.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Shen, L., Yin, H., Sun, L. et al. Correction: Iguratimod attenuated fbrosis in systemic sclerosis via targeting early growth response 1 expression. Arthritis Res Ther 26, 34 (2024). https://doi.org/10.1186/s13075-024-03268-y
Published:
DOI: https://doi.org/10.1186/s13075-024-03268-y